# Intramuscular Midazolam Versus Intravenous Diazepam for Acute Seizure in Children

> **NCT06271096** · EARLY_PHASE1 · COMPLETED · sponsor: **Arooj Khan** · enrollment: 150 (actual)

## Conditions studied

- Seizures

## Interventions

- **DRUG:** Intra muscular Midazolam
- **DRUG:** Intravascular Diazepam

## Key facts

- **NCT ID:** NCT06271096
- **Lead sponsor:** Arooj Khan
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-01
- **Primary completion:** 2022-11-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2024-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06271096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06271096, "Intramuscular Midazolam Versus Intravenous Diazepam for Acute Seizure in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06271096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*